BeStock  
Markets › Compare › LTGO vs AKTS

LTGO vs AKTS

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
LTGO · Latigo Biotherapeutics$13.00 ▼ 1.81%
AKTS · Aktis Oncology$16.15 ▼ 1.52%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

567799120142Aug 7, '26Sep 30, '26Nov 20, '26
  • LTGO -28.8%
  • AKTS -33.1%

Head to head

MetricLTGOAKTS
Price$13.00$16.15
Change today▼ 1.81%▼ 1.52%
Market cap$861.89M$901.14M
Return, 3 months-40.9%-37.8%
Return, year to date––
Return, 1 year––
P/E (TTM)––
P/B2.22.0
P/E percentile vs own 5y89th99th
Dividend yield––
Revenue growth (YoY, latest qtr)–+147.3%
Net profit growth (YoY)+15.5%-92.7%
Gross margin––
Operating margin–-837.5%
Net margin–-706.8%
Return on equity-27.2%-53.6%
Analyst target vs. price+343.6%+126.0%
Analyst buy share100%100%
RSI (14)4146
30-day volatility84.6%62.9%
Max drawdown, 1 year-49.6%-54.7%
Trend readStrong downtrendLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • AKTS is the largest of the group by market value.
  • AKTS has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top